0000874015-22-000157.txt : 20220912 0000874015-22-000157.hdr.sgml : 20220912 20220912190904 ACCESSION NUMBER: 0000874015-22-000157 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220908 FILED AS OF DATE: 20220912 DATE AS OF CHANGE: 20220912 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Swayze Eric CENTRAL INDEX KEY: 0001791058 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 221239521 MAIL ADDRESS: STREET 1: C/O IONIS PHARMACEUTICALS, INC. STREET 2: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2022-09-08 0 0000874015 IONIS PHARMACEUTICALS INC IONS 0001791058 Swayze Eric 2855 GAZELLE COURT CARLSBAD CA 92010 0 1 0 0 EVP Research Common Stock 2022-09-08 4 S 0 460 44.55 D 19892 D Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 20, 2019. By: Patrick R. O'Neil, attorney-in-fact For: Eric Swayze 2022-09-09